The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmHomie Razavi, Achim Kautz, Antonio Javier Blasco et al.|Journal of Viral Hepatitis|2014Cited by 484
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling studyDevin Razavi‐Shearer, Ivane Gamkrelidze, Calvin Q. Pan et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 399
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)Amy D. Proal, E. John Wherry, Michael B. VanElzakker et al.|Nature Immunology|2023Cited by 281
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationHarry L.A. Janssen, Jordan J. Feld, Harald Hofer et al.|Journal of Hepatology|2016Cited by 273
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territoriesDevin Razavi‐Shearer, Nicola Coppola, Hannah Child et al.|Journal of Hepatology|2023Cited by 94